Skip to content
Disclosery

TRV GP IV, LLC

Follow

13F filer, CIK 1688325, Boston, MA

TRV GP IV, LLC reported $163,320,055 across 3 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-08.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-25-007372

Period
2025-06-30
Reported value
$163M
Holdings
3
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0000950123-25-007372, largest first. % of portfolio is the value over $163,320,055, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 16,859,075 shares; 2024Q4: 16,859,075 shares; 2025Q1: 16,859,075 shares; 2025Q2: 16,859,075 shares 16,859,075$86.3M52.85%0Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 6,073,958 shares; 2025Q2: 6,073,958 shares 6,073,958$74.5M45.63%0Timeline
PLRXPLIANT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,132,867 shares; 2024Q4: 2,132,867 shares; 2025Q1: 2,132,867 shares; 2025Q2: 2,132,867 shares 2,132,867$2.47M1.51%0Timeline

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-25-007372 base2025-08-08acceptance time not in the bulk data set